ArticleFrontiers in pharmacology2023

Neurocognitive impairment in females with breast cancer treated with endocrine therapy and CDK4/6 inhibitors: a pharmacovigilance study using the World Health Organization's database.

Rachel Prevost et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.